p53 modifications: exquisite decorations of the powerful guardian
Open accessThe DOI matches its Crossref record; 207 of the 209 references it cites were found in a registry or an index.
Abstract
The last 40 years have witnessed how p53 rose from a viral binding protein to a central factor in both stress responses and tumor suppression. The exquisite regulation of p53 functions is of vital importance for cell fate decisions. Among the multiple layers of mechanisms controlling p53 function, posttranslational modifications (PTMs) represent an efficient and precise way. Major p53 PTMs include phosphorylation, ubiquitination, acetylation, and methylation. Meanwhile, other PTMs like sumoylation, neddylation, O-GlcNAcylation, adenosine diphosphate (ADP)-ribosylation, hydroxylation, and β-hydroxybutyrylation are also shown to play various roles in p53 regulation. By independent action or interaction, PTMs affect p53 stability, conformation, localization, and binding partners. Deregulation of the PTM-related pathway is among the major causes of p53-associated developmental disorders or diseases, especially in cancers. This review focuses on the roles of different p53 modification types and shows how these modifications are orchestrated to produce various outcomes by modulating p53 activities or targeted to treat different diseases caused by p53 dysregulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Acetylation’s role in transcription goes further via mediating the stability of various transcription factors including HIF-1α [74] and p53 [75].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [75]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: The E3 SUMO Ligase PIASy Is a Regulator of Cellular Senescence and Apoptosis
Bischof, O., Schwamborn, K., Martin, N., Werner, A., Sustmann, C., Grosschedl, R., & Dejean, A. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.016 · Cited by 173
RetractedLane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138 · cited 1×
“Originally, p53 was called ‘the guardian of the genome’ (Lane, 1992) for it was found to be activated in response to various types of DNA damages.”
BackgroundIn Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Mechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
ACETYLATION AND METHYLATION OF HISTONES AND THEIR POSSIBLE ROLE IN THE REGULATION OF RNA SYNTHESIS
Allfrey, V. G., Faulkner, R., & Mirsky, A. E. (1964) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.51.5.786 · Cited by 2,639
Coactivator condensation at super-enhancers links phase separation and gene control
Sabari, B. R., Dall’Agnese, A., Boija, A., Klein, I. A., Coffey, E. L., Shrinivas, K., Abraham, B. J., Hannett, N. M., Zamudio, A. V., Manteiga, J. C., et al. (2018) · Science · doi:10.1126/science.aar3958 · Cited by 2,595
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
Self-citationAdeno-associated virus vector as a platform for gene therapy delivery
Wang, D., Tai, P. W. L., & Gao, G. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0012-9 · Cited by 2,444
T antigen is bound to a host protein in SY40-transformed cells
LANE, D. P., & CRAWFORD, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,394
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Self-citationThe HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,054
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Kastenhuber, E. R., & Lowe, S. W. (2017) · Cell · doi:10.1016/j.cell.2017.08.028 · Cited by 1,906
Boija, A., Klein, I. A., Sabari, B. R., Dall’Agnese, A., Coffey, E. L., Zamudio, A. V., Li, C. H., Shrinivas, K., Manteiga, J. C., Hannett, N. M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.042 · Cited by 1,815
Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,813
Concepts in sumoylation: a decade on
Geiss-Friedlander, R., & Melchior, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2293 · Cited by 1,785
A Phase Separation Model for Transcriptional Control
Hnisz, D., Shrinivas, K., Young, R. A., Chakraborty, A. K., & Sharp, P. A. (2017) · Cell · doi:10.1016/j.cell.2017.02.007 · Cited by 1,753
Kruse, J.-P., & Gu, W. (2009) · Cell · doi:10.1016/j.cell.2009.04.050 · Cited by 1,610
Self-citationMutant p53 in Cancer: New Functions and Therapeutic Opportunities
Muller, P. A. J., & Vousden, K. H. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.021 · Cited by 1,545
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308
Post-translational modification of p53 in tumorigenesis
Bode, A. M., & Dong, Z. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1455 · Cited by 1,270
Functions and mechanisms of non-histone protein acetylation
Narita, T., Weinert, B. T., & Choudhary, C. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0081-3 · Cited by 1,232
Proteasome-Independent Functions of Ubiquitin in Endocytosis and Signaling
Mukhopadhyay, D., & Riezman, H. (2007) · Science · doi:10.1126/science.1127085 · Cited by 1,221
DNA damage activates p53 through a phosphorylation–acetylation cascade
Sakaguchi, K., Herrera, J. E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C. W., & Appella, E. (1998) · Genes & Development · doi:10.1101/gad.12.18.2831 · Cited by 1,204
Gene therapy returns to centre stage
Naldini, L. (2015) · Nature · doi:10.1038/nature15818 · Cited by 1,184 · cited 1×
“…patients bearing mutant modification sites, like K120 mutation in various cancers or R249S mutation in HCC (Liao et al., 2017), gene therapy (like adenovirus-based or CRISPR-Cas9-based gene therapy) may serve as an ideal choice in the future (Naldini, 2015; Wang et al., 2019; Yin et al., 2019).”
BackgroundThe multiple mechanisms that regulate p53 activity and cell fate
Hafner, A., Bulyk, M. L., Jambhekar, A., & Lahav, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0110-x · Cited by 1,129
Cytoplasmic functions of the tumour suppressor p53
Green, D. R., & Kroemer, G. (2009) · Nature · doi:10.1038/nature07986 · Cited by 1,106
P53 in survival, death and metabolic health: a lifeguard with a licence to kill.
Kruiswijk, F., Labuschagne, C. F., & Vousden, K. H. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4007 · Cited by 1,080
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., & Gu, W. (2002) · Nature · doi:10.1038/nature737 · Cited by 1,031
Self-citationShieh, S.-Y., Ahn, J., Tamai, K., Taya, Y., & Prives, C. (2000) · Genes & Development · doi:10.1101/gad.14.3.289 · Cited by 972
Deubiquitylating enzymes and drug discovery: emerging opportunities
Harrigan, J. A., Jacq, X., Martin, N. M., & Jackson, S. P. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.152 · Cited by 940
p53 ubiquitination: Mdm2 and beyond
Brooks, C. L., & Gu, W. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.020 · Cited by 924
Self-citationTumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence
Li, T., Kon, N., Jiang, L., Tan, M., Ludwig, T., Zhao, Y., Baer, R., & Gu, W. (2012) · Cell · doi:10.1016/j.cell.2012.04.026 · Cited by 912
Self-citationRegulation of the specific DNA binding function of p53
Hupp, T. R., Meek, D. W., Midgley, C. A., & Lane, D. P. (1992) · Cell · doi:10.1016/0092-8674(92)90562-q · Cited by 909
Targeting mutant p53 for efficient cancer therapy
Bykov, V. J. N., Eriksson, S. E., Bianchi, J., & Wiman, K. G. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.109 · Cited by 889
50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond
Verdin, E., & Ott, M. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3931 · Cited by 877
Acetylation Is Indispensable for p53 Activation
Tang, Y., Zhao, W., Chen, Y., Zhao, Y., & Gu, W. (2008) · Cell · doi:10.1016/j.cell.2008.03.025 · Cited by 838
Self-citationDeacetylation of p53 modulates its effect on cell growth and apoptosis
Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. (2000) · Nature · doi:10.1038/35042612 · Cited by 818
Self-citationRegulation of p53 activity through lysine methylation
Chuikov, S., Kurash, J. K., Wilson, J. R., Xiao, B., Justin, N., Ivanov, G. S., McKinney, K., Tempst, P., Prives, C., Gamblin, S. J., et al. (2004) · Nature · doi:10.1038/nature03117 · Cited by 816
p53 is regulated by the lysine demethylase LSD1
Huang, J., Sengupta, R., Espejo, A. B., Lee, M. G., Dorsey, J. A., Richter, M., Opravil, S., Shiekhattar, R., Bedford, M. T., Jenuwein, T., et al. (2007) · Nature · doi:10.1038/nature06092 · Cited by 807
Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2
Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., & Gu, W. (2003) · Science · doi:10.1126/science.1091362 · Cited by 804
Self-citationp53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage
Liu, L., Scolnick, D. M., Trievel, R. C., Zhang, H. B., Marmorstein, R., Halazonetis, T. D., & Berger, S. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1202 · Cited by 776
Acetylation of the p53 DNA-binding domain regulates apoptosis induction.
Sykes, S. M., Mellert, H. S., Holbert, M. A., Li, K., Marmorstein, R., Lane, W. S., & McMahon, S. B. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.11.026 · Cited by 752
Tip60-Dependent Acetylation of p53 Modulates the Decision between Cell-Cycle Arrest and Apoptosis
Tang, Y., Luo, J., Zhang, W., & Gu, W. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.11.021 · Cited by 727
Self-citationPirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation
Leng, R. P., Lin, Y., Ma, W., Wu, H., Lemmers, B., Chung, S., Parant, J. M., Lozano, G., Hakem, R., & Benchimol, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00193-4 · Cited by 722
DeLeo, A. B., Jay, G., Appella, E., Dubois, G. C., Law, L. W., & Old, L. J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.5.2420 · Cited by 721
The ubiquitin ligase COP1 is a critical negative regulator of p53
Dornan, D., Wertz, I., Shimizu, H., Arnott, D., Frantz, G. D., Dowd, P., O' Rourke, K., Koeppen, H., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02514 · Cited by 704
Ding, K., Lu, Y., Nikolovska-Coleska, Z., Wang, G., Qiu, S., Shangary, S., Gao, W., Qin, D., Stuckey, J., Krajewski, K., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051122a · Cited by 702
Binding and modulation of p53 by p300/CBP coactivators
Lill, N. L., Grossman, S. R., Ginsberg, D., DeCaprio, J., & Livingston, D. M. (1997) · Nature · doi:10.1038/42981 · Cited by 693
Structural Biology of the Tumor Suppressor p53
Joerger, A. C., & Fersht, A. R. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.060806.091238 · Cited by 693
A dynamic role of HAUSP in the p53-Mdm2 pathway
Li, M., Brooks, C. L., Kon, N., & Gu, W. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00157-1 · Cited by 679
Self-citationThe p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches
Joerger, A. C., & Fersht, A. R. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060815-014710 · Cited by 661
Chang, Y. S., Graves, B., Guerlavais, V., Tovar, C., Packman, K., To, K.-H., Olson, K. A., Kesavan, K., Gangurde, P., Mukherjee, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303002110 · Cited by 660
USP10 Regulates p53 Localization and Stability by Deubiquitinating p53
Yuan, J., Luo, K., Zhang, L., Cheville, J. C., & Lou, Z. (2010) · Cell · doi:10.1016/j.cell.2009.12.032 · Cited by 637
Repression of p53 activity by Smyd2-mediated methylation
Huang, J., Perez-Burgos, L., Placek, B. J., Sengupta, R., Richter, M., Dorsey, J. A., Kubicek, S., Opravil, S., Jenuwein, T., & Berger, S. L. (2006) · Nature · doi:10.1038/nature05287 · Cited by 624
Synergistic activation of transcription by CBP and p53
Gu, W., Shi, X.-L., & Roeder, R. G. (1997) · Nature · doi:10.1038/42972 · Cited by 596
Self-citationDiscovery of RG7388, a Potent and Selective p53–MDM2 Inhibitor in Clinical Development
Ding, Q., Zhang, Z., Liu, J.-J., Jiang, N., Zhang, J., Ross, T. M., Chu, X.-J., Bartkovitz, D., Podlaski, F., Janson, C., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400487c · Cited by 595
Chauhan, D., Tian, Z., Nicholson, B., Kumar, K. G. S., Zhou, B., Carrasco, R., McDermott, J. L., Leach, C. A., Fulcinniti, M., Kodrasov, M. P., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.007 · Cited by 589
MDM2–HDAC1-mediated deacetylation of p53 is required for its degradation
Ito, A., Kawaguchi, Y., Lai, C., Kovacs, J. J., Higashimoto, Y., Appella, E., & Yao, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf616 · Cited by 570
Mdm2-Mediated NEDD8 Conjugation of p53 Inhibits Its Transcriptional Activity
Xirodimas, D. P., Saville, M. K., Bourdon, J.-C., Hay, R. T., & Lane, D. P. (2004) · Cell · doi:10.1016/j.cell.2004.06.016 · Cited by 570
ARF-BP1/Mule Is a Critical Mediator of the ARF Tumor Suppressor
Chen, D., Kon, N., Li, M., Zhang, W., Qin, J., & Gu, W. (2005) · Cell · doi:10.1016/j.cell.2005.03.037 · Cited by 544
Self-citationFiscella, M., Zhang, H., Fan, S., Sakaguchi, K., Shen, S., Mercer, W. E., Vande Woude, G. F., O’Connor, P. M., & Appella, E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6048 · Cited by 533
p53 post-translational modification: deregulated in tumorigenesis
Dai, C., & Gu, W. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.09.002 · Cited by 523
Self-citationCoping with stress: multiple ways to activate p53
Horn, H. F., & Vousden, K. H. (2007) · Oncogene · doi:10.1038/sj.onc.1210263 · Cited by 522
Discovery, In Vivo Activity, and Mechanism of Action of a Small-Molecule p53 Activator
Lain, S., Hollick, J. J., Campbell, J., Staples, O. D., Higgins, M., Aoubala, M., McCarthy, A., Appleyard, V., Murray, K. E., Baker, L., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.03.004 · Cited by 522
Acetylation of p53 inhibits its ubiquitination by Mdm2
Li, M., Luo, J., Brooks, C. L., & Gu, W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200578200 · Cited by 503
Self-citationUbiquitin ligases in oncogenic transformation and cancer therapy
Senft, D., Qi, J., & Ronai, Z. A. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.105 · Cited by 489
Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability
Yang, W. H., Kim, J. E., Nam, H. W., Ju, J. W., Kim, H. S., Kim, Y. S., & Cho, J. W. (2006) · Nature Cell Biology · doi:10.1038/ncb1470 · Cited by 486
Posttranslational Modification of p53: Cooperative Integrators of Function
Meek, D. W., & Anderson, C. W. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000950 · Cited by 483
Negative regulation of the deacetylase SIRT1 by DBC1
Zhao, W., Kruse, J.-P., Tang, Y., Jung, S. Y., Qin, J., & Gu, W. (2008) · Nature · doi:10.1038/nature06515 · Cited by 466
Self-citationMolecular basis of USP7 inhibition by selective small-molecule inhibitors.
Turnbull, A. P., Ioannidis, S., Krajewski, W. W., Pinto-Fernandez, A., Heride, C., Martin, A. C. L., Tonkin, L. M., Townsend, E. C., Buker, S. M., Lancia, D. R., et al. (2017) · Nature · doi:10.1038/nature24451 · Cited by 463
Modulation of p53 Function by SET8-Mediated Methylation at Lysine 382
Shi, X., Kachirskaia, I., Yamaguchi, H., West, L. E., Wen, H., Wang, E. W., Dutta, S., Appella, E., & Gozani, O. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.012 · Cited by 462
Arginine methylation regulates the p53 response
Jansson, M., Durant, S. T., Cho, E.-C., Sheahan, S., Edelmann, M., Kessler, B., & La Thangue, N. B. (2008) · Nature Cell Biology · doi:10.1038/ncb1802 · Cited by 462
Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression
Wang, S.-J., Li, D., Ou, Y., Jiang, L., Chen, Y., Zhao, Y., & Gu, W. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.022 · Cited by 462
Self-citationATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins
Waterman, M. J. F., Stavridi, E. S., Waterman, J. L. F., & Halazonetis, T. D. (1998) · Nature Genetics · doi:10.1038/542 · Cited by 460
Non-traditional Functions of Ubiquitin and Ubiquitin-binding Proteins
Schnell, J. D., & Hicke, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r300018200 · Cited by 442
Discovery and Cocrystal Structure of Benzodiazepinedione HDM2 Antagonists That Activate p53 in Cells
Grasberger, B. L., Lu, T., Schubert, C., Parks, D. J., Carver, T. E., Koblish, H. K., Cummings, M. D., LaFrance, L. V., Milkiewicz, K. L., Calvo, R. R., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049137g · Cited by 432
Phosphorylation of p53 Serine 15 Increases Interaction with CBP
Lambert, P. F., Kashanchi, F., Radonovich, M. F., Shiekhattar, R., & Brady, J. N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.33048 · Cited by 423
Takekawa, M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.23.6517 · Cited by 419
The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults
Zacchi, P., Gostissa, M., Uchida, T., Salvagno, C., Avolio, F., Volinia, S., Ronai, Z., Blandino, G., Schneider, C., & Sal, G. D. (2002) · Nature · doi:10.1038/nature01120 · Cited by 414
Activity-Based Chemical Proteomics Accelerates Inhibitor Development for Deubiquitylating Enzymes
Altun, M., Kramer, H. B., Willems, L. I., McDermott, J. L., Leach, C. A., Goldenberg, S. J., Kumar, K. G. S., Konietzny, R., Fischer, R., Kogan, E., et al. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.08.018 · Cited by 402
Discovery of RG7112: a small-molecule MDM2 inhibitor in clinical development
Vu, B., Wovkulich, P., Pizzolato, G., Lovey, A., Ding, Q., Jiang, N., Liu, J.-J., Zhao, C., Glenn, K., Wen, Y., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml4000657 · Cited by 395
Multiple C-Terminal Lysine Residues Target p53 for Ubiquitin-Proteasome-Mediated Degradation
Rodriguez, M. S., Desterro, J. M. P., Lain, S., Lane, D. P., & Hay, R. T. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.22.8458-8467.2000 · Cited by 389
PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints
Lu, X., Nannenga, B., & Donehower, L. A. (2005) · Genes & Development · doi:10.1101/gad.1291305 · Cited by 389
The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response
Zheng, H., You, H., Zhou, X. Z., Murray, S. A., Uchida, T., Wulf, G., Gu, L., Tang, X., Lu, K. P., & Xiao, Z.-X. J. (2002) · Nature · doi:10.1038/nature01116 · Cited by 383
Transcription-independent p53 apoptosis: an alternative route to death
Speidel, D. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.10.002 · Cited by 356
Function and regulation of protein neddylation
Rabut, G., & Peter, M. (2008) · EMBO reports · doi:10.1038/embor.2008.183 · Cited by 350
USP7 small-molecule inhibitors interfere with ubiquitin binding.
Kategaya, L., Di Lello, P., Rougé, L., Pastor, R., Clark, K. R., Drummond, J., Kleinheinz, T., Lin, E., Upton, J.-P., Prakash, S., et al. (2017) · Nature · doi:10.1038/nature24006 · Cited by 333
p53 Acetylation: Regulation and Consequences
Reed, S., & Quelle, D. (2014) · Cancers · doi:10.3390/cancers7010030 · Cited by 332
Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells
Colland, F., Formstecher, E., Jacq, X., Reverdy, C., Planquette, C., Conrath, S., Trouplin, V., Bianchi, J., Aushev, V. N., Camonis, J., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0097 · Cited by 321
Wang, F., Marshall, C. B., & Ikura, M. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1254-4 · Cited by 309
Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy
Yue, X., Zhao, Y., Xu, Y., Zheng, M., Feng, Z., & Hu, W. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.03.030 · Cited by 308
Taira, N., Nihira, K., Yamaguchi, T., Miki, Y., & Yoshida, K. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.007 · Cited by 295
Sun, D., Li, Z., Rew, Y., Gribble, M., Bartberger, M. D., Beck, H. P., Canon, J., Chen, A., Chen, X., Chow, D., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401753e · Cited by 290
Regulation of the p53 response and its relationship to cancer
Meek, D. W. (2015) · Biochemical Journal · doi:10.1042/bj20150517 · Cited by 288
Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate
Knights, C. D., Catania, J., Giovanni, S. D., Muratoglu, S., Perez, R., Swartzbeck, A., Quong, A. A., Zhang, X., Beerman, T., Pestell, R. G., et al. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200512059 · Cited by 287
The Chaperone-associated Ubiquitin Ligase CHIP Is Able to Target p53 for Proteasomal Degradation
Esser, C., Scheffner, M., & Höhfeld, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501574200 · Cited by 261
L'Hernault, S. W., & Rosenbaum, J. L. (1983) · The Journal of cell biology · doi:10.1083/jcb.97.1.258 · Cited by 254
Saito, S., Yamaguchi, H., Higashimoto, Y., Chao, C., Xu, Y., Fornace, A. J., Appella, E., & Anderson, C. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305135200 · Cited by 254
Histone acetylation in gene regulation
Verdone, L. (2006) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/ell028 · Cited by 244
Le Cam, L., Linares, L. K., Paul, C., Julien, E., Lacroix, M., Hatchi, E., Triboulet, R., Bossis, G., Shmueli, A., Rodriguez, M. S., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.031 · Cited by 240
Surf the Post-translational Modification Network of p53 Regulation
Gu, B., & Zhu, W.-G. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4283 · Cited by 235
Regulation of p53 localization
Liang, S., & Clarke, M. F. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02227.x · Cited by 218
Methylation of p53 by Set7/9 Mediates p53 Acetylation and Activity In Vivo
Kurash, J. K., Lei, H., Shen, Q., Marston, W. L., Granda, B. W., Fan, H., Wall, D., Li, E., & Gaudet, F. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.12.025 · Cited by 214
NAT 10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2
Liu, X., Tan, Y., Zhang, C., Zhang, Y., Zhang, L., Ren, P., Deng, H., Luo, J., Ke, Y., & Du, X. (2016) · EMBO reports · doi:10.15252/embr.201540505 · Cited by 214
Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation
Lee, C. W., Ferreon, J. C., Ferreon, A. C. M., Arai, M., & Wright, P. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013078107 · Cited by 213
Methylation-Acetylation Interplay Activates p53 in Response to DNA Damage
Ivanov, G. S., Ivanova, T., Kurash, J., Ivanov, A., Chuikov, S., Gizatullin, F., Herrera-Medina, E. M., Rauscher, F., Reinberg, D., & Barlev, N. A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00460-07 · Cited by 206
FBXO11 Promotes the Neddylation of p53 and Inhibits Its Transcriptional Activity
Abida, W. M., Nikolaev, A., Zhao, W., Zhang, W., & Gu, W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609001200 · Cited by 203
Self-citationOlsson, A., Manzl, C., Strasser, A., & Villunger, A. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402196 · Cited by 200
USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis.
Fan, Y.-H., Cheng, J., Vasudevan, S. A., Dou, J., Zhang, H., Patel, R. H., Ma, I. T., Rojas, Y., Zhao, Y., Yu, Y., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.400 · Cited by 199
Nakamura, S., Roth, J. A., & Mukhopadhyay, T. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9391-9398.2000 · Cited by 199
Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode
Wang, D., Kon, N., Lasso, G., Jiang, L., Leng, W., Zhu, W.-G., Qin, J., Honig, B., & Gu, W. (2016) · Nature · doi:10.1038/nature19759 · Cited by 199
Self-citationIdentification and Characterization of the First Small Molecule Inhibitor of MDMX
Reed, D., Shen, Y., Shelat, A. A., Arnold, L. A., Ferreira, A. M., Zhu, F., Mills, N., Smithson, D. C., Regni, C. A., Bashford, D., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.056747 · Cited by 198
Ou, Y.-H., Chung, P.-H., Sun, T.-P., & Shieh, S.-Y. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-08-0689 · Cited by 198
Takenaka, I., Morin, F., Seizinger, B. R., & Kley, N. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5405 · Cited by 197
CRISPR–Cas: a tool for cancer research and therapeutics
Yin, H., Xue, W., & Anderson, D. G. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0166-8 · Cited by 178
Two Mammalian MOF Complexes Regulate Transcription Activation by Distinct Mechanisms
Li, X., Wu, L., Corsa, C. A. S., Kunkel, S., & Dou, Y. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.07.031 · Cited by 176
Inactivation of HAUSP in vivo modulates p53 function.
Kon, N., Kobayashi, Y., Li, M., Brooks, C. L., Ludwig, T., & Gu, W. (2010) · Oncogene · doi:10.1038/onc.2009.427 · Cited by 176
TRIM59 Is Up-regulated in Gastric Tumors, Promoting Ubiquitination and Degradation of p53
Zhou, Z., Ji, Z., Wang, Y., Li, J., Cao, H., Zhu, H. H., & Gao, W.-Q. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.021 · Cited by 171
Teufel, D. P., Bycroft, M., & Fersht, A. R. (2009) · Oncogene · doi:10.1038/onc.2009.71 · Cited by 159
Ser18 and 23 phosphorylation is required for p53‐dependent apoptosis and tumor suppression
Chao, C., Herr, D., Chun, J., & Xu, Y. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601167 · Cited by 158
Li, H., Cai, X., Shouse, G. P., Piluso, L. G., & Liu, X. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601519 · Cited by 158
Sterner, R., Vidali, G., & Allfrey, V. G. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86524-9 · Cited by 156
MOZ increases p53 acetylation and premature senescence through its complex formation with PML
Rokudai, S., Laptenko, O., Arnal, S. M., Taya, Y., Kitabayashi, I., & Prives, C. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300490110 · Cited by 155
Hsp90 Chaperones Wild-type p53 Tumor Suppressor Protein
Walerych, D., Kudla, G., Gutkowska, M., Wawrzynow, B., Muller, L., King, F. W., Helwak, A., Boros, J., Zylicz, A., & Zylicz, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407601200 · Cited by 154
Phosphorylation of Serine 18 Regulates Distinct p53 Functions in Mice
Sluss, H. K., Armata, H., Gallant, J., & Jones, S. N. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.976-984.2004 · Cited by 152
DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation
Blattner, C., Tobiasch, E., Litfen, M., Rahmsdorf, H. J., & Herrlich, P. (1999) · Oncogene · doi:10.1038/sj.onc.1202480 · Cited by 151
p53 β-hydroxybutyrylation attenuates p53 activity
Liu, K., Li, F., Sun, Q., Lin, N., Han, H., You, K., Tian, F., Mao, Z., Li, T., Tong, T., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1463-y · Cited by 148
Self-citationPhosphorylation of p53 by IκB kinase 2 promotes its degradation by β-TrCP
Xia, Y., Padre, R. C., De Mendoza, T. H., Bottero, V., Tergaonkar, V. B., & Verma, I. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812256106 · Cited by 146
Cell Type- and Promoter-specific Roles of Ser18 Phosphorylation in Regulating p53 Responses
Chao, C., Hergenhahn, M., Kaeser, M. D., Wu, Z., Saito, S., Iggo, R., Hollstein, M., Appella, E., & Xu, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306938200 · Cited by 141
p53 Isoforms and Their Implications in Cancer
Vieler, M., & Sanyal, S. (2018) · Cancers · doi:10.3390/cancers10090288 · Cited by 140
Phosphorylation on Thr-55 by TAF1 Mediates Degradation of p53
Li, H.-H., Li, A. G., Sheppard, H. M., & Liu, X. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00123-6 · Cited by 139
PARP-1 modifies the effectiveness of p53-mediated DNA damage response
Valenzuela, M. T., Guerrero, R., Núñez, M. I., de Almodóvar, J. M. R., Sarker, M., de MURCIA, G., & Oliver, F. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205169 · Cited by 135
Regulation of p53 localization and transcription by the HECT domain E3 ligase WWP1
Laine, A., & Ronai, Z. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209924 · Cited by 133
The cytoplasmic side of p53's oncosuppressive activities
Comel, A., Sorrentino, G., Capaci, V., & Del Sal, G. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.015 · Cited by 126
Wu, S., & Chiang, C. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.83 · Cited by 125
Defective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23
MacPherson, D., Kim, J., Kim, T., Rhee, B. K., van Oostrom, C. T., DiTullio, R. A., Venere, M., Halazonetis, T. D., Bronson, R., de Vries, A., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600363 · Cited by 124
SCFFbxo22-KDM4A targets methylated p53 for degradation and regulates senescence
Johmura, Y., Sun, J., Kitagawa, K., Nakanishi, K., Kuno, T., Naiki-Ito, A., Sawada, Y., Miyamoto, T., Okabe, A., Aburatani, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms10574 · Cited by 118
Chao, C., Wu, Z., Mazur, S. J., Borges, H., Rossi, M., Lin, T., Wang, J. Y. J., Anderson, C. W., Appella, E., & Xu, Y. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00062-06 · Cited by 116
UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53
Liu, L., Yang, M., Peng, Q., Li, M., Zhang, Y., Guo, Y., Chen, Y., & Bao, S. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.09.091 · Cited by 116
The p53 Pathway as a Target in Cancer Therapeutics: Obstacles and Promise
Mandinova, A., & Lee, S. W. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001366 · Cited by 113
Liao, P., Zeng, S. X., Zhou, X., Chen, T., Zhou, F., Cao, B., Jung, J. H., Del Sal, G., Luo, S., & Lu, H. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.11.006 · Cited by 113
Li, D. W.-C., Liu, J.-P., Schmid, P. C., Schlosser, R., Feng, H., Liu, W.-B., Yan, Q., Gong, L., Sun, S.-M., Deng, M., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209334 · Cited by 107
Self-citationModulation of the p53/MDM2 interplay by HAUSP inhibitors
Tavana, O., & Gu, W. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw049 · Cited by 106
Self-citationSelective histone deacetylase small molecule inhibitors: recent progress and perspectives
Qin, H., Li, H., & Liu, F. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1276565 · Cited by 106
Castrogiovanni, C., Waterschoot, B., Backer, O. D., & Dumont, P. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.143 · Cited by 105
Single-nucleotide Polymorphisms in the p53 Signaling Pathway
Grochola, L. F., Zeron-Medina, J., Meriaux, S., & Bond, G. L. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001032 · Cited by 103
Mutation of Mouse p53 Ser23 and the Response to DNA Damage
Wu, Z., Earle, J., Saito, S., Anderson, C. W., Appella, E., & Xu, Y. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2441-2449.2002 · Cited by 103
Transcriptional and epigenetic regulation of the p53 tumor suppressor gene
Saldaña-Meyer, R., & Recillas-Targa, F. (2011) · Epigenetics · doi:10.4161/epi.6.9.16683 · Cited by 101
MSL2 Promotes Mdm2-independent Cytoplasmic Localization of p53
Kruse, J.-P., & Gu, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805658200 · Cited by 100
Self-citationPHF20 is an effector protein of p53 double lysine methylation that stabilizes and activates p53
Cui, G., Park, S., Badeaux, A. I., Kim, D., Lee, J., Thompson, J. R., Yan, F., Kaneko, S., Yuan, Z., Botuyan, M. V., et al. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2353 · Cited by 99
Specific Acetylation of p53 by HDAC Inhibition Prevents DNA Damage-Induced Apoptosis in Neurons
Brochier, C., Dennis, G., Rivieccio, M. A., McLaughlin, K., Coppola, G., Ratan, R. R., & Langley, B. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.5214-12.2013 · Cited by 97
The Methyltransferase Set7/9 (Setd7) Is Dispensable for the p53-Mediated DNA Damage Response In Vivo
Campaner, S., Spreafico, F., Burgold, T., Doni, M., Rosato, U., Amati, B. B., & Testa, G. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.007 · Cited by 95
West, L. E., Roy, S., Lachmi-Weiner, K., Hayashi, R., Shi, X., Appella, E., Kutateladze, T. G., & Gozani, O. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.139527 · Cited by 95
TGF-β upregulates the translation of USP15 via the PI3K/AKT pathway to promote p53 stability
Liu, W.-T., Huang, K.-Y., Lu, M., Huang, H.-L., Chen, C.-Y., Cheng, Y.-L., Yu, H.-C., Liu, S.-Q., Lai, N.-S., & Huang, H.-B. (2016) · Oncogene · doi:10.1038/onc.2016.424 · Cited by 93
Rokudai, S., Aikawa, Y., Tagata, Y., Tsuchida, N., Taya, Y., & Kitabayashi, I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805101200 · Cited by 89
Distinct phosphatases antagonize the p53 response in different phases of the cell cycle
Shaltiël, I. A., Aprelia, M., Saurin, A. T., Chowdhury, D., Kops, G. J. P. L., Voest, E. E., & Medema, R. H. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322021111 · Cited by 89
Liu, H., Li, X., Ning, G., Zhu, S., Ma, X., Liu, X., Liu, C., Huang, M., Schmitt, I., Wüllner, U., et al. (2016) · PLOS Biology · doi:10.1371/journal.pbio.2000733 · Cited by 86
Regulation of p53 family members by the ubiquitin-like SUMO system
Stehmeier, P., & Muller, S. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.01.002 · Cited by 83
HDAC6 deacetylates p53 at lysines 381/382 and differentially coordinates p53-induced apoptosis
Ryu, H.-W., Shin, D.-H., Lee, D. H., Choi, J., Han, G., Lee, K. Y., & Kwon, S. H. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.01.033 · Cited by 82
Synthesis and biological evaluation of thiazole derivatives as novel USP7 inhibitors
Chen, C., Song, J.-M., Wang, J., Xu, C., Chen, C., Gu, W. J., Sun, H., & Wen, X. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.01.018 · Cited by 79
Self-citationp53-Dependent Transcription and Tumor Suppression Are Not Affected in Set7/9-Deficient Mice
Lehnertz, B., Rogalski, J. C., Schulze, F. M., Yi, L., Lin, S., Kast, J., & Rossi, F. M. V. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.006 · Cited by 76
Down-regulation of LATS kinases alters p53 to promote cell migration
Furth, N., Bossel Ben-Moshe, N., Pozniak, Y., Porat, Z., Geiger, T., Domany, E., Aylon, Y., & Oren, M. (2015) · Genes & Development · doi:10.1101/gad.268185.115 · Cited by 74
USP11 regulates p53 stability by deubiquitinating p53
Ke, J., Dai, C., Wu, W.-L., Gao, J., Xia, A.-J., Liu, G., Lv, K., & Wu, C. (2014) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1400180 · Cited by 70
Mutant TP53 Posttranslational Modifications: Challenges and Opportunities
Nguyen, T.-A., Menendez, D., Resnick, M. A., & Anderson, C. W. (2014) · Human Mutation · doi:10.1002/humu.22506 · Cited by 69
Ichwan, S. J. A., Yamada, S., Sumrejkanchanakij, P., Auerkari, E. I., Eto, K., & Ikeda, M.-A. (2005) · Oncogene · doi:10.1038/sj.onc.1209158 · Cited by 68
Ovarian tumor domain-containing protein 1 deubiquitinates and stabilizes p53
Piao, S., Pei, H. Z., Huang, B., & Baek, S. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.02.011 · Cited by 68
The E3 Ligase RING1 Targets p53 for Degradation and Promotes Cancer Cell Proliferation and Survival
Shen, J., Li, P., Shao, X., Yang, Y., Liu, X., Feng, M., Yu, Q., Hu, R., & Wang, Z. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1805 · Cited by 66
TRIM69 inhibits cataractogenesis by negatively regulating p53
Rong, X., Rao, J., Li, D., Jing, Q., Lü, Y., & Ji, Y. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101157 · Cited by 66
PHD3 Regulates p53 Protein Stability by Hydroxylating Proline 359
Rodriguez, J., Herrero, A., Li, S., Rauch, N., Quintanilla, A., Wynne, K., Krstic, A., Acosta, J. C., Taylor, C., Schlisio, S., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.108 · Cited by 65
Jenkins, L. M. M., Yamaguchi, H., Hayashi, R., Cherry, S., Tropea, J. E., Miller, M., Wlodawer, A., Appella, E., & Mazur, S. J. (2009) · Biochemistry · doi:10.1021/bi801716h · Cited by 63
Post-translational modifications of p53 tumor suppressor: determinants of its functional targets.
Taira, N., & Yoshida, K. (2012) · PubMed · doi:10.14670/hh-27.437 · Cited by 61
p53-Ubl fusions as models of ubiquitination, sumoylation and neddylation of p53
Carter, S. A., & Vousden, K. H. (2008) · Cell Cycle · doi:10.4161/cc.7.16.6422 · Cited by 60
OTUD5 Regulates p53 Stability by Deubiquitinating p53
Luo, J., Lu, Z., Lu, X., Chen, L., Cao, J., Zhang, S., Yang, L., & Zhou, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077682 · Cited by 60
Literature-based automated discovery of tumor suppressor p53 phosphorylation and inhibition by NEK2
Choi, B.-K., Dayaram, T., Parikh, N., Wilkins, A. D., Nagarajan, M., Novikov, I. B., Bachman, B. J., Jung, S. Y., Haas, P. J., Labrie, J. L., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806643115 · Cited by 58
Phosphorylation of p53 by TAF1 Inactivates p53-Dependent Transcription in the DNA Damage Response
Wu, Y., Lin, J. C., Piluso, L. G., Dhahbi, J. M., Bobadilla, S., Spindler, S. R., & Liu, X. (2014) · Molecular Cell · doi:10.1016/j.molcel.2013.10.031 · Cited by 57
Ravandi, F., Gojo, I., Patnaik, M. M., Minden, M. D., Kantarjian, H., Johnson-Levonas, A. O., Fancourt, C., Lam, R., Jones, M. B., Knox, C. D., et al. (2016) · Leukemia Research · doi:10.1016/j.leukres.2016.07.004 · Cited by 57
Hua, W.-K., Qi, J., Cai, Q., Carnahan, E., Ayala Ramirez, M., Li, L., Marcucci, G., & Kuo, Y.-H. (2017) · Blood · doi:10.1182/blood-2017-03-771386 · Cited by 57
Specific inhibition of Mdm2-mediated neddylation by Tip60
Dohmesen, C., Koeppel, M., & Dobbelstein, M. (2008) · Cell Cycle · doi:10.4161/cc.7.2.5185 · Cited by 50
RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma
Yu, S., Dai, J., Ma, M., Xu, T., Kong, Y., Cui, C., Chi, Z., Si, L., Tang, H., Yang, L., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1488-2 · Cited by 49
Reverting p53 activation after recovery of cellular stress to resume with cell cycle progression
Lazo, P. A. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.02.005 · Cited by 47
SIRT3 deacetylates and promotes degradation of P53 in PTEN-defective non-small cell lung cancer
Xiong, Y., Wang, L., Wang, S., Wang, M., Zhao, J., Zhang, Z., Li, X., Jia, L., & Han, Y. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2537-9 · Cited by 46
Mutant and wild-type p53 form complexes with p73 upon phosphorylation by the kinase JNK
Wolf, E. R., McAtarsney, C. P., Bredhold, K. E., Kline, A. M., & Mayo, L. D. (2018) · Science Signaling · doi:10.1126/scisignal.aao4170 · Cited by 44
USP49 participates in the DNA damage response by forming a positive feedback loop with p53
Tu, R., Kang, W., Yang, X.-F., Zhang, Q., Xie, X., Liu, W., Zhang, J., Zhang, X.-D., Wang, H., & Du, R. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0475-3 · Cited by 44
Mdm proteins: critical regulators of embryogenesis and homoeostasis
Moyer, S. M., Larsson, C. A., & Lozano, G. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx004 · Cited by 42
PAK4 Phosphorylates p53 at Serine 215 to Promote Liver Cancer Metastasis
Xu, H., Lai, W.-L., Liu, H.-F., Wong, L. L.-Y., Ng, I. O., & Ching, Y. P. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3373 · Cited by 41
A novel Aurora-A-mediated phosphorylation of p53 inhibits its interaction with MDM2
Hsueh, K.-W., Fu, S., Chang, C., Chang, Y., & Lin, C. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.11.005 · Cited by 39
Effect of Phosphorylation on the Structure and Fold of Transactivation Domain of p53
Kar, S., Sakaguchi, K., Shimohigashi, Y., Samaddar, S., Banerjee, R., Basu, G., Swaminathan, V., Kundu, T. K., & Roy, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106915200 · Cited by 39
Negative auto-regulators trap p53 in their web
Zhou, X., Cao, B., & Lu, H. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx001 · Cited by 36
Poly(ADP-ribose) polymerase-1 inhibits ATM kinase activity in DNA damage response
Watanabe, F., Fukazawa, H., Masutani, M., Suzuki, H., Teraoka, H., Mizutani, S., & Uehara, Y. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.031 · Cited by 33
The GAS41-PP2Cβ Complex Dephosphorylates p53 at Serine 366 and Regulates Its Stability
Park, J. H., Smith, R., Shieh, S.-Y., & Roeder, R. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.c110.210211 · Cited by 32
Chen, J., Dai, G., Wang, Y., Wang, S., Pan, F., Xue, B., Zhao, D., & Li, C. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.05.047 · Cited by 32
UBE4B targets phosphorylated p53 at serines 15 and 392 for degradation
Du, C., Wu, H., & Leng, R. P. (2015) · Oncotarget · doi:10.18632/oncotarget.6555 · Cited by 32
IKKβ activates p53 to promote cancer cell adaptation to glutamine deprivation
Gabra, M. B. I., Yang, Y., Lowman, X. H., Reid, M. A., Tran, T. Q., & Kong, M. (2018) · Oncogenesis · doi:10.1038/s41389-018-0104-0 · Cited by 32
USP3 stabilizes p53 protein through its deubiquitinase activity
Fu, S., Shao, S., Wang, L., Liu, H., Hou, H., Wang, Y., Wang, H., Huang, X., & Lv, R. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.036 · Cited by 30
Zhang, L., Jin, Y., Yang, H., Li, Y., Wang, C., Shi, Y., & Wang, Y. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz078 · Cited by 27
Cited by
p53 in ferroptosis regulation: The new weapon for the old guardian
Liu, Y., & Gu, W. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00943-y · Cited by 540
Self-citationUnderstanding the complexity of p53 in a new era of tumor suppression
Liu, Y., Su, Z., Tavana, O., & Gu, W. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.04.009 · Cited by 495
Self-citationZhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al. (2023) · MedComm · doi:10.1002/mco2.261 · Cited by 442
iPLA2β-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4
Chen, D., Chu, B., Yang, X., Liu, Z., Jin, Y., Kon, N., Rabadan, R., Jiang, X., Stockwell, B. R., & Gu, W. (2021) · Nature Communications · doi:10.1038/s41467-021-23902-6 · Cited by 348
Self-citationGain-of-function mutant p53 in cancer progression and therapy
Zhang, C., Liu, J., Xu, D., Zhang, T., Hu, W., & Feng, Z. (2020) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaa040 · Cited by 334
Metadata
- Authors
- Liu, Y., Tavana, O., & Gu, W.
- Affiliations
- Columbia University (US)
- Herbert Irving Comprehensive Cancer Center (US)
- Corresponding author
- Gu, Wei
- Venue
- Journal of Molecular Cell Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-07
- Volume
- 11
- Issue
- 7
- Pages
- 564-577
- ISSN
- 1674-2788 (ISSN-L)
- 1759-4685
- PMC
- PMC6736412
- OpenAlex
- W2961184804
- Cited by
- 392
- References
- 209
- Citations by year
- 2026: 31 · 2025: 47 · 2024: 49 · 2023: 73 · 2022: 83 · 2021: 63 · 2020: 40 · 2019: 5
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Molecular Cell Biology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute of the National Institutes of Health (5R01CA193890, 5R01CA085533, 5R01CA190477, 5R01CA216884)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- p53, post-translational modification, phosphorylation, ubiquitination, acetylation, methylation, SUMOylation, neddylation, O-GlcNAcylation, ADP-ribosylation, hydroxylation, β-hydroxybutyrylation, p53 stabilization, tumor suppression, stress response, cancer, developmental disorders
- MeSH terms
- Animals, Humans, Neoplasms, Protein Processing, Post-Translational, Tumor Suppressor Protein p53, History, 20th Century, History, 21st Century, Protein Stability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.